Comparison of the Effects of Conventional Fixed ICS/LABA Combined Therapy Versus Combined Maintenance and Reliever ICS/Formoterol Therapy on the Treatment of Adherence and Inhaler Satisfaction of Asthma Patients Who Received Inhaler Education

被引：0

作者：

Gemicioglu, B. ^{[1
]}

Sekibag, Y. ^{[1
]}

Borekci, S. ^{[1
]}

机构：

[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Pulm Dis, Istanbul, Turkey

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A3014

引用

页数：1

共 5 条

[1] Adherence, quality of life, and satisfaction with conventional fix combined therapy versus maintenance and reliever therapy in patients with asthma after inhaler training
Sekibag, Yonca
Borekci, Sermin
Gemicioglu, Bilun
JOURNAL OF ASTHMA, 2022, 59 (09) : 1819 - 1830
[2] Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
Patel, Mitesh
Pilcher, Janine
Beasley, Richard
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 451 - 454
[3] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
Mehta, R.
Farrell, C.
Kilbride, S.
Zhu, C.
Brooks, J.
Barnhart, F.
Birk, R.
Lipson, D. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[4] A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI)
Al-Ahmad, Mona
Webb, David
RESPIRATORY MEDICINE, 2022, 194
[5] Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy
Hozawa, Soichiro
Terada, Michikazu
Hozawa, Maki
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 27 (02) : 190 - 196

← 1 →